New antibody therapy shows promising results for advanced, treatment-refractory pediatric brain cancer

New antibody therapy shows promising results for advanced, treatment-refractory pediatric brain cancer

31/07/2022 Ella Ye

New antibody therapy shows promising results for advanced, treatment-refractory pediatric brain cancer

AFCR is registered in Hong Kong with the Inland Revenue Department. Our file number with the Inland Revenue Department is 91/7750. AFCR has a Certificate of Incorporation number 994957 with Company Registry.

Tel: (852) 2156 9684

Fax: (852) 2156 9685

Unit 1503, Tower II, Metroplaza, 223 Hing Fong Road, Kwai Chung, Hong Kong

Follow Us On :

©2024 Asian Fund for Cancer Research, All rights reserved. Website designed and maintained by USABAL Solutions

©2024 Asian Fund for Cancer Research, All rights reserved. Website designed and maintained by USABAL Solutions